| G Wormser | | Lyme diagnostic tests (Immunetics, Bio-Rad, Biopeptides, Diaspex, Abbott Laboratories) | | Self-disclosure, IDSA Guidelines 20065Self-disclosure, New England Journal of Medicine 20076 |
| | Lyme vaccines (Baxter, AstraZeneca, Biopeptides) | | |
| | Expert witness for medical malpractice involving Lyme disease | | |
| R Dattwyler | | Lyme diagnostic tests (Biopeptides and Baxter) | | Self-disclosure, IDSA Guidelines 2006 |
| | Lyme vaccines (Baxter, Biopeptides) | | Self-disclosure, BMJ Lyme Wars 20077 |
| | US patent 7008625 Recombinant Constructs of Bb | | Self-disclosure, see individual patents listed in conflict column |
| | Provisional patent 60/812,595 on a live “bacterial vaccine”, PCT/US2005/023106 “oral vaccine for Borrelia”, a wildlife vaccine | | Brook Technologies Release8 |
| | Provisional patent 60/799,016, “Peptide Diagnostic Agent for Lyme” | | |
| | Expert witness for medical malpractice involving Lyme disease | | |
| E Shapiro | | Vaccines: Sanofi-Aventis, NIH Grants K24RR022477, KL2RR024138, and UL1RR024139. | | Self-disclosure, IDSA Guidelines 2006Self-disclosure, New England Journal of Medicine 2007 |
| | Expert testimony: medical malpractice and unprofessional conduct actions | | Self-disclosure, American Academy of Neurology 20079 |
| | Insurance: reviews Lyme disease disability claims for Metropolitan Life Insurance | | |
| A Steere | | Lyme vaccines (Baxter, GlaxoSmithKline) | | Self-disclosure, IDSA Guidelines 2006 |
| | Lyme diagnostic tests (Viramed) | | Self-disclosure, Nature 200610 |
| J Halperin | | Vaccines: serves as an expert witness on behalf of Lymerix (GlaxoSmithKline) in litigation regarding adverse effects from first generation vaccines (ongoing) | | Self-disclosure, IDSA Guidelines 2006 |